These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4141047)

  • 1. [Medical treatment of prostatic adenoma. Urinary flow data].
    Giglio V; Campo B; Motta M
    Minerva Urol; 1972; 24(3):104-7. PubMed ID: 4141047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Raveron treatment of prostatic adenoma in the light of uroflowmetry (on the basis of 20 cases)].
    Janosz F; Zieliński J
    Pol Przegl Chir; 1975 Nov; 47(11A):1441-4. PubMed ID: 54910
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urine flowmetry in patients with prostatic adenoma treated with Raveron].
    Steinmetz L; Adamkiewicz K
    Pol Przegl Chir; 1974 Oct; 46(10A):1375-82. PubMed ID: 4139698
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical treatment of prostatic obstruction. An objective assessment.
    Claridge M
    Invest Urol; 1975 Mar; 12(5):401-4. PubMed ID: 46221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of urination disorders with Raveron].
    Ichim V
    Z Urol Nephrol; 1970 Apr; 63(4):255-60. PubMed ID: 4109019
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M; Trucchi E
    Minerva Urol; 1972; 24(5):167-72. PubMed ID: 4141050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tadenan treatment of prostatic adenoma].
    Danilov VV; Elisseva EV; Vasil'chenko AV
    Urologiia; 2009; (2):68, 70-3. PubMed ID: 19526878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of raveron and levorin on urination recovery in prostatic adenoma and chronic prostatitis].
    Savin VF; Antonov NM; Arkannikov AB
    Urol Nefrol (Mosk); 1982; (2):22-4. PubMed ID: 6177084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of the effect of prostate extracts].
    Costa J; Guedes JM; Reis MO
    J Med (Oporto); 1965 Dec; 58(196):1024-7. PubMed ID: 4159123
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
    Stepanov VN; Teodorovich OV; Seregin AV; Kadyrov ZA
    Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of conservative treatment in prostatic adenoma].
    Kulikov SK
    Vrach Delo; 1982 Feb; (2):93-5. PubMed ID: 6175102
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of patients with benign prostatic hyperplasia using the selective alpha-blocker alfuzosin].
    Mazo EB; Matushevskiĭ IA; Nikitin IuIu
    Ter Arkh; 1997; 69(10):79-82. PubMed ID: 9471799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of lower urinary tract function in patients with adenoma of the prostate].
    Kulikov SK
    Vrach Delo; 1979 Dec; (12):23-6. PubMed ID: 93348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA; Vinarov AZ
    Urol Nefrol (Mosk); 1996; (4):25-7. PubMed ID: 8928344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual laser ablation of the prostate (VLAP): an effective alternative treatment of benign prostatic hyperplasia.
    Mattelaer P; Jung P; Wolff J; Jakse G
    Acta Urol Belg; 1995 Sep; 63(3):45-9. PubMed ID: 7484522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On drug therapy of prostatic hypertrophy].
    Rieben W
    Praxis; 1967 Jul; 56(30):1042-7. PubMed ID: 4180980
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumorous prostatic diseases. I. Prostatic adenoma--genesis, clinical aspects, therapy].
    Reichelt H
    Z Allgemeinmed; 1974 May; 50(15):688-93. PubMed ID: 4137484
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of mepartricin in the medical treatment of benign prostatic adenoma].
    Casella G; Barbaro A
    Arch Sci Med (Torino); 1978; 135(1):95-8. PubMed ID: 76466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of alfuzosin (dalfaz) in patients with benign prostatic hyperplasia].
    Tkachuk VN; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (2):38-40. PubMed ID: 9577703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.